The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goodman, S.
Right arrow Articles by Chang, M. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goodman, S.
Right arrow Articles by Chang, M. D.

The Journal of Immunology, Vol 155, Issue 3 1210-1217, Copyright © 1995 by American Association of Immunologists


ARTICLES

Mutational analysis of two DR alpha residues involved in dimers of HLA- DR molecules

S Goodman, T Sawada, JA Barbosa, B Cole, R Pergolizzi, J Silver, E Mellins and MD Chang
Department of Pediatrics, Children's Hospital, Philadelphia, PA 19104, USA.

Crystallographic analysis of HLA-DR1 molecules reveals a "dimer of dimers" with two reciprocal salt bridges between Glu 88 and Lys 111 of the two DR alpha chains. To determine whether these amino acids are critical for Ag presentation, we generated a panel of human B cell transfectants expressing DR alpha chains with mutations at residues 88, 111, or both. The mutant DR alpha chains, paired with endogenous DR3 beta chain, form cell surface dimers that retain epitopes recognized by a panel of anti-DR3 Abs. Replacement of Glu 88 with Ala (88A) selectively eliminates the ability to activate an alloreactive (anti- DR3) T cell clone. Mutant DR molecules with Lys substituted for Glu 88 (88K) fail to activate an alloreactive, an Ag-specific, and a peptide- specific T cell line. The DR alpha 88 mutants bind an exogenously supplied DR3-specific peptide and the mutant DR molecules migrate as dimers on SDS-PAGE, implying that their defective Ag presentation is not due to an inability to bind antigenic peptides. In contrast, substitution of Lys 111 with either Ala (111A) or Glu (111E) does not abrogate Ag presentation. Further, the defect introduced by Glu 88 to Lys mutation (88K) is not overcome by compensatory Lys to Glu mutation at position 111 (111E). Taken together, these results indicate an important functional or structural role for position 88 of the DR alpha chain, but argue against a requirement for interaction between DR alpha 88 and 111 during Ag-specific T cell stimulation.


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
H. Li, Y. Zhao, Y. Guo, Z. Li, L. Eisele, and W. Mourad
Zinc Induces Dimerization of the Class II Major Histocompatibility Complex Molecule That Leads to Cooperative Binding to a Superantigen
J. Biol. Chem., March 2, 2007; 282(9): 5991 - 6000.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Hitzel, U. Gruneberg, M. van Ham, J. Trowsdale, and N. Koch
Sodium Dodecyl Sulfate-Resistant HLA-DR ""Superdimer"" Bands Are in Some Cases Class II Heterodimers Bound to Antibody
J. Immunol., April 15, 1999; 162(8): 4671 - 4676.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. H. Schafer, S. Malapati, K. K. Hanfelt, and S. K. Pierce
The Assembly and Stability of MHC Class II-({alpha}{beta})2 Superdimers
J. Immunol., September 1, 1998; 161(5): 2307 - 2316.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
B. A. Fields, B. Ober, E. L. Malchiodi, M. I. Lebedeva, B. C. Braden, X. Ysern, J.-K. Kim, X. Shao, E.S. Ward, and R. A. Mariuzza
Crystal Structure of the V[IMAGE] Domain of a T Cell Antigen Receptor
Science, December 15, 1995; 270(5243): 1821 - 1824.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.